Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Kedudukan dalam Saham #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Harga Saham
$2.49
Modal Pasaran
$4.47M
Perubahan (1 hari)
-4.01%
Perubahan (1 tahun)
678.16%
Negara
MY
Perdagangan BioNexus Gene Lab Corporation (BGLC)

Kategori

Pendapatan untuk BioNexus Gene Lab Corporation (BGLC)
Pendapatan pada Sep 2025 TTM: $-2.37M
Menurut laporan kewangan terkini BioNexus Gene Lab Corporation, pendapatan semasa syarikat ialah $-2.37M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $-2.61M, penurunan berbanding pendapatan pada tahun 2022 yang berjumlah $-303.66K. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi BioNexus Gene Lab Corporation dari 2016 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-2.37M 48.64%
2024 $-1.59M -38.84%
2023 $-2.61M 758.71%
2022 $-303.66K -129.12%
2021 $1.04M -17.40%
2020 $1.26M -557.92%
2019 $-275.71K -560.27%
2018 $59.90K -150.16%
2017 $-119.41K 14,201.08%
2016 $-835.00 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$7.27B -306,699.14%
US
$4.23B -178,668.26%
US
$1.32B -55,960.65%
US
$2.63B -111,037.93%
CN
$1.43B -60,508.64%
US